Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 371,300 shares, a growth of 11.8% from the May 15th total of 332,200 shares. Based on an average daily volume of 152,700 shares, the days-to-cover ratio is currently 2.4 days. Approximately 2.4% of the shares of the company are short sold.
Analyst Ratings Changes
Separately, Taglich Brothers restated a “speculative buy” rating on shares of Cosmos Health in a research note on Tuesday, February 20th.
Check Out Our Latest Analysis on Cosmos Health
Cosmos Health Stock Down 2.3 %
Hedge Funds Weigh In On Cosmos Health
An institutional investor recently bought a new position in Cosmos Health stock. Armistice Capital LLC bought a new position in Cosmos Health Inc. (NASDAQ:COSM – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned 7.89% of Cosmos Health at the end of the most recent reporting period. Institutional investors own 12.61% of the company’s stock.
About Cosmos Health
Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.
Further Reading
- Five stocks we like better than Cosmos Health
- Investing in Travel Stocks Benefits
- MarketBeat Week in Review – 6/10 – 6/14
- The How And Why of Investing in Oil Stocks
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- Investing in Construction Stocks
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.